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ABSTRACT: We have developed new procedures to examine
the early steps in fibrin polymerization. First, we isolated
fibrinogen monomers from plasma fibrinogen by gel filtration.
Polymerization of fibrinogen monomers differed from that of
plasma fibrinogen. The formation of protofibrils was slower
and the transformation of protofibrils to fibers faster for the
fibrinogen monomers. Second, we used formaldehyde to
terminate the polymerization reactions. The formaldehyde-
fixed products obtained at each time point were examined by
dynamic light scattering and transmission electron microscopy
(TEM). The data showed the formaldehyde-fixed products
were stable and representative of the reaction intermediates.
TEM images showed monomers, short oligomers, protofibrils,
and thin fibers. The amount and length of these species varied with time. Short oligomers were less than 5% of the molecules at
all times. Third, we developed models that recapitulate the TEM images. Fibrin monomer models were assembled into
protofibrils, and protofibrils were assembled into two-strand fibers using Chimera software. Monomers were based on fibrinogen
crystal structures, and the end-to-end interactions between monomers were based on D-dimer crystal structures. Protofibrils
assembled from S-shaped monomers through asymmetric D:D interactions were ordered helical structures. Fibers were modeled
by duplicating a protofibril and rotating the duplicate 120° around its long axis. No specific interactions were presumed. The two
protofibrils simply twisted around one another to form a fiber. This model suggests that the conformation of the protofibril per se
promotes the assembly into fibers. These findings introduce a novel mechanism for fibrin assembly that may be relevant to other
biopolymers.
Many studies have provided insight into the mechanismsthat promote polymerization of fibrin monomers into
fibers. The classic light scattering studies of Hantgan and
Hermans showed polymerization occurs in two steps: end-to-
end polymerization of monomers into protofibrils and lateral
association of protofibrils into fibers.1 When the light scattering
data were correlated with electron microscopy images, the two
polymerization steps were identified as (1) the formation of
half-staggered and double-stranded protofibrils and (2) a
dramatic increase in fiber diameter.2 Subsequent studies have
confirmed this two-step model and the structure of the
protofibril intermediate. Of note, modeling studies conducted
by Weisel and co-workers also showed fibrin assembly and
fibrin structure are kinetically determined.3,4 In particular,
kinetic analysis of images obtained by transmission electron
microscopy (TEM) showed that reactions between oligomers
are important for the polymerization of monomers into
protofibrils.4 More recently, Bernocco et al. studied the early
stages of fibrin polymerization using stopped-flow multiangle
laser light scattering technology.5 They found the first step of
polymerization is compatible with the formation of double-
stranded, half-staggered semiflexible protofibrils of a limited
length, and subsequently, such protofibrils assemble into fibers.
The molecular interactions that promote the polymerization
of monomers into protofibrils are well-known.6 Fibrin
monomers contain three distinct structural regions: two distal
D regions linked by coiled-coil connectors to one central E
region. The D regions contain the polymerization sites known
as holes “a”, and the central E region contains two
polymerization sites known as knobs “A”. The knobs become
exposed after thrombin cleaves fibrinopeptide A (FpA) from
fibrinogen. Because the E region lies between two symmetric D
regions, the reciprocal knob:hole, “A:a”, interactions lead to a
double-stranded protofibril with a half-staggered overlap
between molecules in different strands. The end-to-end
alignment of monomers in each protofibril strand forms the
D:D interface. Even though the adjoined D regions are
identical, crystallography studies have shown the D:D interface
is asymmetric.
In contrast, the molecular interactions that promote assembly
of protofibrils into fibers and the structures formed during this
assembly remain unresolved. Several studies support a role for
“B:b” knob:hole interactions and/or αC−αC interactions.6,7
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Our experiments with recombinant fibrinogen variants indicate
“B:b” interactions support protofibril formation and thereby
enhance protofibril assembly,8 while αC−αC interactions have
an only modest influence on lateral aggregation.9 Doolittle’s
group proposed a detailed theoretical model of fibrin
formation.10 In this model, two interactions support protofibril
assembly: a primary interaction between γ-chains and a
concomitant if subsidiary interaction between β-chains. These
interactions were predicated on the intermolecular packing
arrangements observed in crystal structures of fragment D from
fibrinogen and the D-dimer isolated from cross-linked fibrin.
These hypothetical possibilities have not been tested
experimentally.
For the studies described here, we developed a novel method
to “freeze” polymerization and provide “snapshots” of the
different polymerization phases. We monitored thrombin-
catalyzed polymerization of fibrinogen monomers, stopping
the reactions at three time points: when protofibrils are
forming, when protofibrils are growing, and when assembly of
protofibrils into fibers is initiated. Because we stopped
polymerization by the addition of formaldehyde, we were
able to examine the polymer products by both dynamic light
scattering (DLS) and transmission electron microscopy
(TEM). Our DLS data showed that the formaldehyde-fixed
products were stable and represented snapshots of the real-time
DLS measurements. Our TEM data indicate fibrin monomers
rapidly attached to protofibrils. We also developed three-
dimensional models that accurately matched the structure of
protofibrils and fibers seen by TEM in this study and in several
other studies (for example, refs 4 and 11). These models were
based on the crystal structures of fibrinogen and the D-dimer
isolated from fibrin. They suggest that the shape of fibrinogen
impacts the shape of the protofibril and the shape of the
protofibril per se promotes the assembly of protofibrils into
fibers. In contrast to previous models, no specific interactions
were stipulated for the assembly of two protofibrils into a fiber.
■ EXPERIMENTAL PROCEDURES
Protein Preparation. Human plasma fibrinogen (Enzyme
Research Laboratories, Inc.) was dialyzed overnight against 20
mM HEPES (pH 7.4) and 150 mM NaCl (HBS). Prior to
polymerization studies, fibrinogen was diluted to 0.8 mg/mL in
HBS with 1 mM CaCl2. Fibrinogen concentrations were
determined from A280, using an extinction coefficient of 1.51 for
a 1 mg/mL solution.
Gel Filtration Chromatography. Fibrinogen monomers
were prepared as previously described.9 Briefly, dialyzed
fibrinogen was diluted to 8.0 mg/mL in HBS, filtered with a
0.22 μm GV DURAPORE centrifugal filter, and injected into a
Superdex-200 column (GE Healthcare, Piscataway, NJ)
equilibrated with HBS. Fractions (120 μL/tube) were collected
and analyzed by DLS with a DLS plate reader (DynaPro, Waytt
Technology, Santa Barbara, CA) and the absorbance at 280
with a Nanodrop spectrophotometer (Nanodrop 2000,
Thermo Scientific, Wilmington, DE). The peak fractions
containing fibrinogen monomers were combined together,
adjusted to 0.8 mg/mL in HBS with 1 mM CaCl2, and stored at
4 °C until they were used within 48 h.
Fibrinogen Polymerization. All buffers and fibrinogen
samples were filtered (0.22 μm GV DURAPORE centrifugal
filter) prior to use. Thrombin-catalyzed polymerization was
monitored as the increase in the average hydrodynamic radius
in a DLS plate reader. Reactions were conducted at ambient
temperature with 0.4 mg/mL fibrinogen and 0.01 unit/mL
human thrombin in HBS with 1 mM CaCl2. Reactions were
initiated by adding 60 μL of thrombin to 60 μL of fibrinogen
and mixing thoroughly; the mixture was transferred into the
plate reader wells. Polymerization was monitored for 60 min
after the addition of thrombin. Data were collected every 10 s at
25 °C.
Formaldehyde “Stopped” Reactions. Reactions were
conducted under the same conditions described in Fibrinogen
Polymerization. Polymerization was initiated by mixing
fibrinogen (0.8 mg/mL) with an equivalent volume of
thrombin (0.02 unit/mL) in HBS with 1 mM CaCl2 and
immediately dividing the samples into three tubes (100 μL/
tube). Twenty microliters of 0.5 M formaldehyde (prepared
from paraformaldehyde, analyzed grade, Fisher Scientific12) was
added at 5, 8, and 12 min, and the samples were rapidly mixed.
The 0 min sample was prepared by mixing 50 μL of HBS buffer
with 1 mM CaCl2 with 50 μL of fibrinogen (0.8 mg/mL) and
then adding 20 μL of 0.5 M formaldehyde. Samples were kept
at room temperature for 30 min and 24 h and examined in the
DLS plate reader.
Immunoblot Analysis of Fibrinogen. Polymerization was
performed using the same conditions described in Form-
aldehyde “Stopped” Reactions. Reactions were stopped by
adding SDS buffer under reduced conditions at 5, 8, and 12
min. The 0 min sample was prepared by adding SDS buffer
under reduced conditions to fibrinogen. The samples were run
on 8% polyacrylamide gels, transferred onto a nitrocellulose
membrane, and developed with Aα chain specific monoclonal
antibody Y-18 as previously described.13 The blot was
developed with ECL Western blotting detection reagents (GE
Healthcare), and the bands were quantified using ImageJ
(http://rsbweb.nih.gov/ij/).
Transmission Electron Microscopy (TEM). Formalde-
hyde-treated products were characterized by TEM. Form-
aldehyde-fixed polymer products at 0, 5, 8, and 12 min were
diluted and transferred onto the 400 mesh, glow-discharged
copper grids coated with Formvar/Carbon and then negatively
stained with filtered 2% aqueous uranyl acetate essentially as
described previously.4 The samples were observed using a LEO
EM-910 transmission electron microscope operating at 80 kV
(Carl Zeiss SMT, Peabody, MA), and images were taken using
a Gatan Orius SC1000 CCD camera with Digital Micrograph
version 3.11.0 (Gatan, Inc., Pleasanton, CA) with a
magnification of 100000×. We diluted samples as needed to
obtain good TEM images with appropriate numbers of objects.
We measured three aliquots of each sample, and the images are
reproducible. All images were analyzed with ImageJ to measure
the length and width of each object (monomer, oligomer,
protofibril, and fiber). All the data were the average values of
each species at different time points based on at least 10 images.
The numbers of each species were counted by visual
observation.
Modeling. We used UCSF Chimera (http://www.cgl.ucsf.
edu/chimera/) to model the structures seen by TEM.14
Molecular graphics images were produced using the UCSF
Chimera package from the Resource for Biocomputing,
Visualization, and Informatics at the University of California,
San Francisco (supported by National Institutes of Health
Grant P41 RR001081). The crystal structures of fibrinogen
[Protein Data Bank (PDB) entries 3GHG and 1M1J] were
used as a base for the monomer, and the D-dimer crystal
structures (PDB entries 3H32 and 1FCZ) were used as a base
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for the end-to-end interactions between monomers. Chimera
allowed assembly of a composite model by producing multiple
copies of a crystal structure, each of which could be moved and
turned without disturbing the molecule’s shape.
We assembled a protofibril beginning with the fibrin dimer.
Two fibrinogens in the same orientation were juxtaposed
visually to mimic the D:D interaction of the D-dimer. The
juxtaposed molecules were then superimposed onto the D-
dimer structures, and manual adjustments were made to
minimize the differences. The transformation matrix between
these two fibrinogens was repeated and used in a Chimera
command to generate more monomers, attaching one
monomer per iteration onto one end of the chain. This
generated a helix structure. Small adjustments were made in the
transformation matrix such that the chain more closely
resembled the curvature seen in the TEM images. These
steps established the transformation matrix of the D:D
interaction in the dimer. The fibrin trimer was modeled from
the dimer by positioning the third monomer in an inverted
orientation such that the E region of the new monomer was
centered over the D:D interface and the “a” sites in the new
monomer were positioned as needed to form “A:a” interactions
with the two E regions of the dimer. Each chain of the trimer
was then elongated using the same transformation matrix that
established the D:D interaction in the dimer.
We assembled a fiber from two protofibrils. One protofibril
was duplicated, and the duplicate was rotated along the long
axis to separate the two structures. A rotation of 120° generated
a model that closely resembled the TEM images.
■ RESULTS
Polymerization was monitored by DLS. Using the DynaPro
DLS plate reader, we determined that the average hydro-
dynamic radius of plasma fibrinogen was 16.1 nm. A histogram
of these data (Figure 1A) showed a relatively wide size
distribution, indicating polydispersity. Following gel filtration
chromatography, DLS analysis of the main peak (Figure 1B)
showed a monodisperse sample whose hydrodynamic radius
corresponded to that of the fibrinogen monomer (10.0 nm).15
The hydrodynamic radius of monomeric fibrinogen remained
constant for hours at ambient temperature, several days at 4 °C,
and several months at −20 °C. Sodium dodecyl sulfate−
polyacrylamide gel electrophoresis (SDS−PAGE) analysis
showed no degradation of the fibrinogen monomers during
gel filtration (Figure S1 of the Supporting Information).
Immunoblot analysis showed Factor XIII eluted with the
fibrinogen monomers (Figure S2 of the Supporting Informa-
tion).
We measured thrombin-catalyzed polymerization of fibri-
nogen before and after gel filtration by DLS; the data are shown
in Figure 2. Both curves can be characterized by three stages: an
early stage when the slope is relatively shallow, a midstage when
the slope is steep, and a final stage when the curves reach a
plateau. These stages reflect the steps of polymerization: the
formation of protofibrils, the assembly of protofibrils into fibers,
and the stable clot in which the fiber diameter remains
constant. Both curves clearly showed all three stages, but their
shapes were markedly different from one another. For
polydisperse fibrinogen without gel filtration, the slope was
comparatively low for 10 min. Thereafter, the slope became
increasingly steeper until the average radius reached a plateau at
28 min. For monodisperse fibrinogen after gel filtration, the
slope of the early stage was lower, around nearly zero. The
midstage was initiated later, at 14 min, and the hydrodynamic
radius increased dramatically. The curve reached a plateau
sooner, around 22 min. Thus, the transformation of the
protofibril to the final fiber took only 8 min for the monomer
sample. In contrast, with polydisperse fibrinogen, the trans-
formation of the protofibril to the fiber took ∼18 min. Finally,
the diameter of fibers formed from fibrinogen monomers was
much larger than the diameter of fibers formed from
polydisperse fibrinogen. The average final radius for fibrinogen
monomers (∼1500 nm) was approximately twice the average
final radius for polydisperse fibrinogen (∼800 nm). Note that
the average radius was determined by DynaPro software
assuming a spherical particle, which of course is not the case for
fibrin polymers or fibers. Nevertheless, the difference in the
plateau values indicates the fibers formed from polydisperse
Figure 1. Hydrodynamic radius determined by DLS. The plots show
the percent distribution of size in a representative fibrinogen sample
(A) before and (B) after gel filtration chromatography. DLS was
performed on samples of 0.4 mg/mL fibrinogen in HBS [20 mM
HEPES and 150 mM NaCl (pH 7.4)] as described in Experimental
Procedures.
Figure 2. Thrombin-catalyzed polymerization monitored by DLS.
Polymerization was initiated by adding thrombin (0.1 unit/mL) to
fibrinogens (0.4 mg/mL) in HBS with 1 mM calcium, as described in
Experimental Procedures. Polymer formation was measured as the
average hydrodynamic radius as a function of time. The data are the
average of three independent experiments with fibrinogen samples (■)
before and (●) after gel filtration chromatography. The inset expands
the first 15 min of the reactions.
Biochemistry Article
dx.doi.org/10.1021/bi500986z | Biochemistry 2014, 53, 7824−78347826
samples are thinner than fibers formed from monodisperse
samples. These data show that the aggregates present in plasma
fibrinogen substantially influence the kinetics of polymerization.
This conclusion is consistent with our recent studies that
showed that polymerization was monitored by turbidity.9 The
physiological significance of our findings is unknown. Never-
theless, as discussed previously,9 studies suggest that such
aggregates indeed promote thrombotic disease. In the
subsequent experiments reported here, we used only fibrinogen
monomers.
Formaldehyde is able to “freeze” polymerization. We
performed polymerization using the conditions described in
the legend of Figure 2, adding formaldehyde to samples without
thrombin and 5, 8, and 12 min after the addition of thrombin.
As shown in Table 1, the average hydrodynamic radius of the
formaldehyde-treated samples increased with time, similar to
the increase in radius seen in real time. We measured the radius
of the fixed products 30 min and 24 h after the addition of
formaldehyde and found these were the same. Thus, the
addition of formaldehyde stops polymerization and “freezes”
the polymers as stable products.
The hydrodynamic radius of fibrinogen (0 min) with
formaldehyde was the same as that without formaldehyde.
This result shows that the level of formation of intermolecular
products by reaction of monomers with formaldehyde was low,
below the detection limit of DLS. This result indicates that the
addition of formaldehyde per se did not impact the structure or
distribution of complexes. For example, the formaldehyde-fixed
oligomers seen by TEM were formed by polymerization, not by
formaldehyde-induced cross-linking. The hydrodynamic radius
Table 1. Average Hydrodynamic Radii (nanometers) of Formaldehyde-Fixed Productsa
samples analyzed by DLS 0 min 5 min 8 min 12 min
fixed products measured after 30 min 10.1 ± 0.1 18.6 ± 0.6 37.5 ± 3.9 100.4 ± 5.4
fixed products measured after 24 h 10.2 ± 0.2 18.7 ± 0.3 35.8 ± 6.1 93.4 ± 7.0
real-time polymerization 10.0 ± 0.1 13.0 ± 0.5 15.9 ± 0.5 20.5 ± 0.6
aFormaldehyde was added at different times before (0 min) and after addition of thrombin to fibrinogen. The radii for the formaldehyde-fixed
products were determined 30 min or 24 h after the addition of formaldehyde. The real-time data correspond to those in Figure 2. The data are the
mean radii ± the standard deviation from three experiments.
Figure 3. Transmission electron microscopy (TEM) images of formaldehyde-fixed products negatively stained with uranyl acetate. Polymerization
was performed as described in the legend of Figure 2 and stopped by addition of formaldehyde prior to (0 min) or 5, 8, or 12 min after the addition
of thrombin. A representative set of “fixed” polymer samples is shown. The scale bar is 100 nm, which is approximately twice the length of a
fibrinogen monomer. Images below each field show individual structures on an expanded scale. Schematic representations of structures seen in 5 min
are shown: (A) monomer, (B) trimer, (C) tetramer, and (D) hexamer.
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of the formaldehyde-treated polymerization products was larger
than the radius during real-time polymerization at the times of
formaldehyde addition. For example, the hydrodynamic radius
of the formaldehyde-fixed products at 5 min lies between the
radii during real-time polymerization at 8 and 12 min. These
data suggest that there is a 3−7 min delay to completely stop
polymerization (see Table 1 and Figure 2). Considered
altogether, the DLS data indicate that polymerization continues
after the addition of formaldehyde, that formaldehyde links
monomers that are within one polymer, and that once
polymerization is arrested the formaldehyde-linked products
are stable.
TEM provides clear snapshots of formaldehyde-fixed
products. Representative TEM images of formaldehyde-fixed
products (Figure 3) show the progression from monomers to
oligomers, protofibrils, and fibers. The morphologies of
individual monomers and monomers within each structure
are evident. In particular, the half-staggered, double-stranded
morphology of the protofibril was unmistakable (Figure 3, 5
min), and fibers of two or more protofibrils were clearly evident
(Figure 3, 8 and 12 min). Our TEM images of protofibrils are
similar to but apparently more uniform than those of Medved
et al.11 This uniformity may be a consequence of formaldehyde
fixation prior to microscopy, the use of fibrinogen monomers,
or both. For quantitative analysis of the images, we measured
the length and width of each structure using ImageJ. We
defined three structures by their width: monomers with a width
between 4 and 6 nm, oligomers and protofibrils with a width
between 8 and 13 nm, and fibers with a width greater than 13
nm. Before the addition of thrombin, only monomers were
seen, as expected for fibrinogen purified by size exclusion
chromatography. Short oligomers and protofibrils were
observed when formaldehyde was added 5 min after thrombin.
At 8 min, the oligomers and protofibrils increased in both size
and number, and a small number of fibers appeared. At 12 min,
more fibers were observed and the length of the longest fibers
reached ∼2 μm. The TEM data also showed that even at the
Figure 4. Quantitative assessment of the formaldehyde-fixed products. The histograms show the time-dependent analysis for (A) the percentage of
each form (monomers, oligomers, and fibers) at each time, (B) the average length of each form (nanometers ± the standard deviation) at each time,
and (C) the percentage of molecules found in each structure (measured as the number of monomers) at each time (5 min, blue; 8 min, green; 12
min, red); data for the smallest structures defined as protofibrils are colored yellow. The asterisk denotes molecules in long protofibrils containing
more than 25 monomers and fibers.
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earliest time (5 min), the polymerization products were
relatively heterogeneous with a large distribution of sizes.
A quantitative assessment of the TEM images is shown in
Figure 4. Figure 4A shows a histogram of the structures plotted
as the percent of the three forms: monomers, oligomers
including protofibrils, and fibers. Monomers decreased from
100% at 0 min to 94, 85, and 61% at 5, 8, and 12 min,
respectively. Oligomers and protofibrils increased from 6% at 5
min to 13 and 26% at 8 and 12 min, respectively. Fibers first
appeared at 8 min, increasing from 2% at 8 min to 13% at 12
min. We note that ∼77% of the fibers seen at 12 min were
found in tangles, such as that shown in Figure 3. We found that
the percent of each fibrin form did not change when the
formaldehyde-stopped reaction mixtures were diluted prior to
analysis by TEM. Thus, the morphologic data, like the DLS
data, showed the formaldehyde-fixed products are stable.
The average length of each form at different times is shown
in Figure 4B. The length of the fibrin monomers remained ∼48
nm throughout. The length of oligomers and protofibrils
increased continuously from ∼200 nm at 5 min to ∼550 nm at
12 min. Fibers increased in length from ∼600 nm at 8 min to
∼950 nm at 12 min. Considering all the TEM images, the
average widths (±standard deviation) for monomers, oligomers
including protofibrils, and fibers were 5.5 ± 1.3, 10.8 ± 2.2, and
22.3 ± 7.7 nm, respectively.
Surprisingly, only a few short oligomers were observed in
these TEM images from 0 to 12 min. Figure 4C shows the data
as the percent of fibrin(ogen) molecules found in each form at
Figure 5. Special structure of the two-strand fibers. Two images were selected from the TEM images of formaldehyde-fixed products at 12 min. The
scale bar is 100 nm.
Figure 6. Models of (A) the protofibril and (B) the two-strand fiber. The models were generated with UCSF Chimera using the crystal structures of
fibrinogen (PDB entry 1M1J) and the fibrin D-dimer (PDB entry 1FCZ). Two monomers (red) were joined to make a dimer by mimicking the D:D
interface of the D-dimer. The trimer (A1) was made by adding a third monomer (blue) to align the “knobs” in the dimer with the “holes” in the third
monomer. The double-stranded protofibril was formed by applying a transformation matrix that elongated the trimer by one monomer per iteration,
as described in the text. The individual strands of the protofibril are colored blue and red. Four views are shown (A2−A5): front (A2), top (A3),
close-up of the front (A4), and a perspective angle (A5). The model protofibril was scaled to and compared with a representative TEM protofibril
(A6). The model of the two-strand fiber was developed by superimposing two protofibrils (one red, one blue) and rotating one of these 120° along
its long axis (B1). Four views of the fiber are shown (B2−B5): front (B2), top (B3), close-up of the front (B4), and a perspective angle (B5). The
model fiber was scaled to and compared with a representative TEM fiber (B6). Videos of these two models are provided in the Supporting
Information.
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each time. Note that the Y-axis in panel C differs from that in
panel A; in panel C, the Y-axis is the percentage of total
molecules that are monomers, while in panel A, the Y-axis is the
percentage of each species out of the total number of objects.
We found oligomers were less than 5% of the molecules at all
times if we defined oligomers with eight or more monomers as
protofibrils. As the reaction proceeded, the number and length
of protofibrils increased. At 5 min, the longest protofibrils
contained 20 monomers. Over time, an increasing number of
molecules were involved in long protofibrils (>25 monomers)
and thin fibers. At 12 min, long protofibrils and thin fibers
constituted ∼34% of all molecules. The very low representation
of oligomers (<8 monomers) suggests that their lifetime is very
short and that they quickly become protofibrils.
Most monomers observed in TEM are fibrinogen. To
determine whether the monomers observed in the TEM images
were fibrinogen or fibrin, we measured the fractional
concentration of fibrinogen. We stopped polymerization by
adding SDS buffer and analyzed the products on immunoblots
developed with monoclonal antibody Y-18 that recognizes
fibrinogen but not fibrin. The data (Figure S3 of the Supporting
Information) showed that the concentrations of fibrinogen
were 78, 63, and 31% of the total fibrin(ogen) molecules at 5, 8,
and 12 min, respectively. These values were very similar to the
relative concentrations of monomers shown in Figure 4C (82,
53, and 28%, respectively). These findings indicate that the
monomers in the TEM images were almost all fibrinogen. The
high concentrations of fibrinogen are expected in our reaction
mixtures in which thrombin concentrations were low. Our
findings indicate that once cleaved by thrombin, fibrin
monomers are quickly conjugated with other fibrin forms.
Protofibrils twist to make fibers. Most interestingly, some
images obtained after ≥8 min showed one special structure
(Figure 5): fibers formed from two protofibrils twisted around
each other. At one end, the protofibrils were separated,
indicating they had not yet had a chance to form a complete
fiber when polymerization was stopped by the addition of
formaldehyde. These images suggest that the two protofibrils
interacted at one end and twisted around each other step by
step to form a two-stranded fiber.
A three-dimensional model recapitulates the architecture of
the protofibrils and two-stranded fibers. We developed models
for protofibrils and two-strand fibers using UCSF Chimera.14
Each model was based on one crystal structure of fibrinogen
and one crystal structure of the D-dimer. We used four crystal
structures: the human fibrinogen structure (PDB entry 3GHG),
the chicken fibrinogen structure (PDB entry 1M1J), and two
human D-dimer structures (PDB entries 3H32 and 1FZC) that
have different D:D interfaces. The four models developed from
these structures were remarkably similar. In particular, all
models showed the curved and twisted shapes that are
described below. Considered together, the protofibril and
fiber models indicate that the assembly of protofibrils into fibers
is determined by the shape of the protofibril, which in turn is
determined by the shape of the monomer. We present the
model assembled from chicken fibrinogen (PDB entry 1M1J)
using the D-dimer interface from the structure that mimics the
“knob:hole” interactions found in human fibrin (PDB entry
1FCZ).
We modeled the protofibril starting with a trimer, as shown
in Figure 6A. We first aligned the longitudinal interface
between two monomers (colored red) to match the D:D
interface in the D-dimer structure. We inserted the third (blue)
monomer based on the “A:a” “knob:hole” interactions that are
known to be critical to protofibril formation. Because knob “A”
is not visible in any crystal structure, one must make
assumptions about the orientation of the knobs “A” in one
monomer to the holes “a” in the adjacent monomer. Similar
assumptions were made in a previous model of the protofibril.10
We joined the knobs “A” from the central regions of the two
monomers (Figure 6A1, red) with the holes “a” from the distal
ends of a third monomer (blue), so this monomer faced the
dimer. The trimer was expanded into a double-stranded
protofibril in two stages, each of which repeatedly added one
monomer at a time to the structure. In the first stage, red
monomers were appended to form more D:D interactions. In
each iteration, the left-hand monomer of the new D:D
interaction was positioned adjacent to the right-hand monomer
of the previous D:D interaction such that their relative
positions and orientations matched those of the two original
red monomers. Note that this added monomers onto the strand
of the initial trimer and maintained the asymmetry that is found
in the D:D interaction. In the second stage, we replicated blue
monomers in the second protofibril strand and appended these
one by one onto the original blue monomer using the relative
transformation determined in stage 1. Thus, the second strand
was identical to the first strand. Using this transformation
repeatedly, it was a simple process to grow the double-stranded
structures. As a consequence of this, all of the monomers’
relative pairwise positions (and thus interactions) are identical
throughout the protofibril.
Images of this model are shown in Figure 6A2−A5; videos
showing rotation around the long axis and the center point of
the model are available in the Supporting Information (Movies
V1 and V2). When the structures are viewed from different
perspectives, their shapes in the model vary; some segments
appear as single strands, and some segments show gaps
between the two strands. Of note, the strands in the model
protofibril twist around one another (Figure 6A2−A4) with a
pitch of two monomers, and the protofibril itself is spirally
curved (Figure 6A5) with a pitch of seven monomers. The twist
of the strands and the spiral curvature of the protofibril were
present in all of our models, including those based on a
different D:D interface (PDB entry 3H32) or on the human
fibrinogen structure (PDB entry 3GHG). These modeling
experiments indicate that the twist and the spiral curvature of
the structure are inherent properties of a double-stranded
protofibril that is uniformly assembled from the S-shaped fibrin
monomers appended through asymmetric D:D interactions.
These shapes are similar to the shapes of the protofibrils seen in
our TEM images, as illustrated in Figure 6A6.
We also used the UCSF Chimera assembly tools to generate
a model of a fiber constructed from two protofibrils. Images
from this model are shown in Figure 6B; videos showing
rotation around the long axis and the center point of the model
are available in the Supporting Information (Movies V3 and
V4). We duplicated the original protofibril, superimposed the
two images, and then rotated the duplicate 120° around its long
axis to separate the two strands as shown in Figure 6B1. The
resultant structure was a two-strand fiber in which the two
protofibrils twisted around one another with the same seven-
monomer pitch as the protofibril (Figure 6B2−B5). It is not an
accident that the two-strand fiber has the same pitch as a
protofibril. Technically, the helix in the protofibril dictates the
twist in the fiber. This simple modeling step suggests that the
assembly of two protofibrils into a fiber reflects the twist and
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spiral curvature of the protofibril. The model fiber is similar to
the two-strand fibers seen in our TEM images, as illustrated in
Figure 6B6.
■ DISCUSSION
Advantages of the “Formaldehyde-Fixed” Approach.
In previous studies of fibrin structures formed during the early
stages of polymerization, the reaction products were not fixed
prior to TEM such that the experimental conditions might
influence the outcome.2,11 For example, oligomers could
dissociate when reaction mixtures are diluted prior to
application onto the microscopy grid. To overcome this
potential flaw, we stopped the reactions by adding form-
aldehyde. We found the TEM images of the formaldehyde-fixed
products were unchanged by dilution in buffer. DLS of the fixed
products confirmed that formaldehyde stopped the reactions
and showed that the formaldehyde-fixed products were stable.
Thus, the TEM images reflect the morphology of the products
present at the time of addition of formaldehyde. Our images are
reminiscent of images of protofibrils and fibers whose reactions
were arrested by dilution into 0.05 M ammonium acetate and
immediately placed on the microscopy grid.4 This morpho-
logical similarity indicates that formaldehyde treatment per se
did not substantially alter the polymer structures.
Comparing the DLS of the fixed products to the DLS of real-
time samples at the time of fixation suggests a time delay in
stopping the reactions. Because DLS measures changes with
time, it may be misleading to compare the real-time data, where
the structures are not only moving but also changing with time,
to those of the formaldehyde-stopped reactions, where the
structures are stable. Nevertheless, we note that this time delay
suggests the structures in the fixed samples are indeed different
from those at the equivalent real time. One might anticipate
this difference if the larger structures were more likely to be
fixed by formaldehyde. This suggests that the smaller structures
are very short-lived relative to the time needed to covalently
link the monomers. The tangled structure seen at 12 min in
Figure 3 should also be considered when comparing the real-
time DLS to that of the fixed samples. Such large structures
would have a disproportionate influence on the value of the
average DLS, as such structures would be less mobile than the
same structures moving independently. We conclude that
formaldehyde-fixed approach provides an accurate representa-
tion of the structures formed early in polymerization.
Implications of the Quantitative TEM Results. The data
shown in Figure 4C differ from similar histograms reported by
Weisel et al.4 These differences could all arise from differences
in experimental conditions. We saw a larger fraction of
monomers, mostly fibrinogen, at all times, consistent with the
low thrombin concentration (0.25 unit/mg of fibrinogen) used
here. In contrast, the monomer peak in the previous study is
undoubtedly fibrin, as the thrombin concentration was high
(100 units/mg of fibrinogen). Thus, the previous histograms
provide a more accurate estimate of the lifetime of the fibrin
monomer. We saw a small and relatively uniform fraction of
oligomers and protofibrils; they report dips and peaks
indicating accumulation of specific intermediates. Weisel et al.
used plasma fibrinogen in their studies. Our gel filtration data
suggest histograms of this fibrinogen would show oligomers.
Thus, the oligomer intermediates that change during the
reaction could reflect the presence of larger species in the
starting material. We saw no evidence of stable oligomers. This
finding indicates that specific intermediates do not accumulate
during thrombin-catalyzed polymerization of monomeric
fibrinogen. Lastly, our histogram peaks are shifted to the
right, indicating assembly into large structures occurred more
rapidly in our experiments. This difference would be anticipated
from the DLS data (Figure 2). The DLS curves show larger
species accumulate earlier during polymerization of plasma
fibrinogen relative to polymerization of fibrinogen monomers.
Irrespective of these differences, both analyses showed
oligomers were quickly assembled into protofibrils and fibers.
In recent studies, Weisel and his colleagues have compared
quantitative TEM data with structures visualized by spinning
disc confocal microscopy. These complementary approaches
allowed the visualization of real-time polymerization of
hydrated samples alongside the high-resolution characterization
of the structures present at specific times. These studies used
kinetic conditions similar to ours, 0.07 unit of thrombin/mg of
fibrinogen, though with plasma fibrinogen. We compared the
snapshots at our three time points to the three earliest time
points in this study where the percents of monomers are nearly
the same: 81, 52, and 28% for our studies and 78, 55, and 40%
for theirs, respectively. This comparison shows the results from
the two studies are quite similar. At the earliest time, both
samples were heterogeneous though more so in our sample. We
saw small amounts (≤2%) of every species, monomer through
dodecamer, plus a few larger, while they saw a decreasing
fraction with increasing size, i.e., fewer trimers than dimers.
They did not see oligomers of five, six, or seven monomers,
while we saw these species in essentially all our samples. In
both studies, fibers were first observed at the second time, and
the fractions of fibers were similar, ∼10%. The spinning disc
confocal microscopy data confirmed that fibers were present,
but not the primary structure at this time. In both studies, the
fraction of fibers increased and the fraction of protofibrils
decreased when comparing the third time to the second time.
This finding suggests that the assembly of protofibrils into
fibers was the dominant process when the third sample was
obtained. That is, the fibers are growing in diameter more
rapidly than protofibrils are forming. Both analyses show a
small fraction of oligomers are present throughout these times,
indicating that these oligomers assemble rapidly and that they
add to both protofibrils and fibers. Neither set of data could
distinguish whether oligomers add to fibers by assembling
alongside or elongating the protofibrils existing within the
fibers.
Implications of Modeling. We developed models based
on the S-shape of fibrinogen and the asymmetric D:D interface.
We assembled a trimer and added monomers to build a half-
staggered, double-stranded protofibril. Examination of the
model protofibril illustrates that the varying TEM images
seen here and in published reports can arise from different
perspectives of the same structure. The constraints used in
building this model induced a twist of one chain around the
second. Several early studies have also noted a twisted structure.
Indeed, a hint of twisting was first perceived more than 40 years
ago.16 In 1990, Medved et al.17 published remarkable TEM
images that clearly showed crossover points of the chains within
a protofibril as expected if the chains twist around one another.
Our model also showed the twisted strands form a spiral
structure. This suggests that protofibrils are ordered helical
structures. Both the twisted strands and the spiral structure
arise from the asymmetric D:D interface that is evident in
almost all crystal structures. Indeed, the one variant fibrinogen,
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γN308 K, whose crystal structure showed a symmetric D:D
interface does not form stable protofibrils.18
We then assembled a fiber by simply rotating one of two
identical, superimposed protofibrils. The similarity between the
model fiber and the fibers seen in TEM leads us to hypothesize
that the modeling recapitulates the assembly of two protofibrils
into a fiber. The modeling suggests that it is the conformation
of the protofibril per se, both its twisted surface and its spiral
curvature, that promotes the assembly. The protofibril surfaces
must be compatible, but specific interactions between
protofibrils were not stipulated. The structures shown in
Figure 5 are consistent with this model: the two protofibrils
assembled from one end, twisting around one another to form
the two-protofibril fiber. The assembly was stopped by the
addition of formaldehyde before the two protofibrils were fully
annealed, forming the Y-shaped structures.
Our model shows the protofibril and the fiber have the same
helical pitch. Indeed, the helical pitch of the protofibril, seven
monomers, sets the helical pitch of the fiber. In 1987, Weisel et
al. observed a similar helical structure in fibers and measured
the average pitch as 1930 ± 280 nm, equivalent to 43 ± 6
monomers.19 This pitch is much larger than the pitch of our
model and the structures shown in our TEM images. The
difference may arise from the conditions of polymerization, as
these conditions will affect the morphology of the fibers. The
earlier studies were completed at much higher thrombin and
fibrinogen concentrations. Further, it is possible that addition of
formaldehyde preserved the steeper pitch observed in our
fibers.
All previous models of the assembly of protofibrils into fibers
stipulate specific intermolecular interactions. Assembly occurs
after the protofibrils reach a specific length, approximately 16
monomers. This observation suggests that multiple weak
interactions between protofibrils are required to initiate
assembly. As FpB release correlates with the growth in fiber
diameter, “B:b” interactions were the first implicated in
assembly.20 However, even this early study showed “B:b”
interactions were not required. Fibers were formed when
fibrinogen was cleaved by snake venoms that released only FpA,
such that “B:b” interactions were not present. Subsequent
studies resolve this apparent inconsistency.21 These suggest the
release of FpB per se and “B:b” interactions enhance the
formation of protofibrils and consequently enhance assembly of
protofibrils into fibers. Many studies have shown the αC
domains influence polymerization and fiber diameter.22 Gorkun
et al. correlated electron microscopy and turbidity studies using
fibrinogen preparations missing one or both of these domains.
These experiments led to an appealing model in which the αC
regions interact intramolecularly in fibrinogen but intermolec-
ularly in fibrin. These intermolecular interactions promote
assembly. Studies with recombinant fibrinogen lacking the αC
regions indicate these regions do indeed influence polymer-
ization, but the effect is modest.9,23,24 Without αC, the fiber
diameter was slightly smaller, indicating the assembly of
protofibrils was inhibited but not eliminated. Thus, like the
“B:b” interactions, the αC:αC interactions were not required
for the assembly of protofibrils.
These findings naturally evoke the hypothesis that two, or
more, types of specific interactions work together to support
the assembly of protofibrils into fibers. This hypothesis has
been tested with recombinant fibrinogens that combined the
loss of the αC domain with other changes that influence
polymerization: BβD398A and γE132A (L. Huang, L. Ping, O.
V. Gorkun, and S. T. Lord, unpublished data). The individual
variants showed little or no change in turbidity that could
reflect changes in the assembly of protofibrils, while the double
mutations (αC/BβD398A and αC/γE132A) show only modest
changes in turbidity. These data show that the loss of both
αC:αC and “B:b” interactions, or other pairs of interactions, did
not eliminate the assembly of protofibrils into fibers. Perhaps an
additional, unidentified specific interaction is also required. We
examined the interface between the two protofibrils (orange
and blue) in our model fiber. We used UCSF Chimera to
determine the point of closest approach and identified the atom
pair: the side chain oxygen for chain residue Thr 358 and the
backbone amide for chain reside Glu 270. Thr 358 lies within
one half of the primary interacting site, residues 350−360, in
the molecular model of fibrin assembly proposed by Doolittle’s
group.10 Residue Glu 270, however, is not within the proposed
complementary segment of residues 370−380. Thus, assembly
of the protofibrils in our model does not recapitulate the
previously proposed interface. For those interested in additional
molecular details, our model can be accessed via the CISMM
web server (http://cismm.cs.unc.edu/wp-content/uploads/
2014/10/fiber_pdb.zip).
The only variant fibrinogen whose protofibrils appear to be
unable to assemble into fibers is a hybrid molecule in which the
normal human αC domain was replaced with the analogous
chicken αC domain.25 Light scattering studies indicate that
protofibrils formed with this hybrid; however, fibers did not
form, and no fibrin clot was evident. It is difficult to interpret
these data. TEM studies showed the hybrid fibrinogen structure
differs from that of normal fibrinogen. Approximately 89% of
the hybrid molecules are U-shaped or complicated shaped
under conditions where 90% of normal fibrinogen is S-shaped
(L. Huang, L. Ping, C. Powierza, O. V. Gorkun, and S. T. Lord,
unpublished data). This observation supports our model in
which the S shape of fibrinogen has a critical role in
polymerization. It should be noted, however, that natural
chicken fibrinogen is slow to polymerize when tested under
similar conditions. The natural protein does form a fibrin clot,
although one with relatively thin fibers (L. Huang, L. Ping, O.
V. Gorkun, and S. T. Lord, unpublished data). These studies
suggest that αC regions do have a role in fiber assembly,
although in this case, an inhibitory role.
Alternatively, the long-held premise that protofibril assembly
requires specific interactions may be incorrect. We propose a
model in which assembly of protofibrils is driven by topology
rather than multiple specific interactions. There is no clear
precedence for such a conformation-driven assembly. A critical
role for conformation has been suggested in two earlier studies
that also examined electron microscopy images. In a study with
modified fibrin, Wade et al. proposed that the protofibril has a
tendency to twist and assemble with other protofibrils to form
an ordered twisted fibril.26 They noted that tensions in the
right-handed twist of the protofibril are partially relieved when
it assembles into a left-handed coil. In other words, the authors
proposed the driving force for fiber assembly is the tension
introduced by the twist in the protofibril. One year later, Ferry’s
group examined images that showed branching junctions in fine
clots.27 These authors suggest the strength of the junctions is
enhanced because of topological constraints provided by
twisting rather than the noncovalent interactions between
protofibrils. Thus, these authors limit the role of conformation
to the branch points. We propose that the spiral conformation
of the twisted protofibril drives assembly of protofibrils into
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fibers. We note that the spiral of the model protofibril is right-
handed while the coil of the model fiber is left-handed. Thus,
tension in the protofibril could be reduced by assembly into the
fiber. This discussion suggests a possible precedence for our
model, the assembly of α-helices into coiled coils. This
assembly is also dependent on conformation. Again, right-
handed structures, the α-helices, are assembled in a left-handed
coil. We also note a recent study that may be relevant to our
model. This study suggests the “A:a” interactions could provide
stability to a protofibril structure under tension. The data
showed “A:a” interactions exhibit “catch-slip” kinetics, indicat-
ing that these interactions exist in two states.28 Perhaps the
assembly of monomers into protofibrils is supported by the
“catch” bond, providing stability to a right-handed, twisted,
spiral. During subsequent assembly into a left-handed fiber, the
“A:a” interaction “slips” into the alternative state that is stable
within the fiber. This idea is highly speculative. Nevertheless, it
seems reasonable to propose that the “A:a” interactions in
protofibrils differ from those in fibers.
In conclusion, our data are consistent with many previous
studies. They show protofibrils are twisted structures and
protofibril assembly into fibers can lead to fiber branching. In
contrast, our model is unique. This model shows protofibrils
are ordered helical structures and suggests that the assembly of




Nonreduced SDS−PAGE gel results of fibrinogen before and
after purification (Figure S1), immunoblot analysis of
fibrinogen fractions from size exclusion chromatography
(Figure S2), immunoblot analysis of the fibrinogen monomer
at different polymerization time points to quantify the
remaining monomers (Figure S3), and rotation videos of the
protofibril and fibers around the long axis and the center point
of the models (Movies S1−S4). This material is available free of
charge via the Internet at http://pubs.acs.org.
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